Italia Markets open in 34 mins
Dow Jones
32.717,60 +323,35 (+1,00%) Nasdaq
11.926,24 +210,16 (+1,79%) Nikkei 225
27.782,93 -100,85 (-0,36%) EUR/USD
1,0840 -0,0007 (-0,0650%) BTC-EUR
26.368,36 +844,53 (+3,31%) CMC Crypto 200
620,73 +19,76 (+3,29%)
Syros Pharmaceuticals, Inc. (0LC7.L)
LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 06:51PM BST
| Chiusura precedente | 3,0420 |
| Aperto | 0,0000 |
| Denaro | 0,0000 x N/D |
| Lettera | 0,0000 x N/D |
| Min-Max giorno | 0,0000 - 0,0000 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 1,55 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,8250 |
| Prossima data utili | 15 mag 2023 - 19 mag 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Syros and Tyme Technologies Announce Stockholder Approval of Merger
-- Combined Company to Trade on Nasdaq Under Ticker “SYRS” ---- Syros Announces 1-for-10 Reverse Stock Split of Common Stock -- CAMBRIDGE, Mass. and BEDMINSTER, N.J., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and Tyme Technologies, Inc. (NASDAQ:TYME) today announced the results of the special meetings of the stockholders of Syros and TYME, respectively, each held on September 15, 20
© 2023 Yahoo. Tutti i diritti riservati.
